Myelofibrosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Myelofibrosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Report Format: PDF+Excel | Report ID: SR112023A4451
Buy Now

Market Overview:

The global myelofibrosis treatment market size reached US$ 642.4 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 881.2 Million by 2027, exhibiting a growth rate (CAGR) of 5.32% during 2022-2027.

Myelofibrosis is a chronic leukemia disease that affects the blood-forming tissues in the body. It increases the risk of bleeding, which leads to extensive scarring in bone marrow, severe anemia, weakness, and fatigue. It can be diagnosed using physical examination, blood tests, bone marrow tests, imaging tests, and human leukocyte antigen (HLA) typing. At present, various methods of treating myelofibrosis are available, depending on the patients’ symptoms and circumstances. These methods include targeted drug therapy, chemotherapy, surgical interventions, radiation therapy, and stem cell transplantation. In addition, several drugs are being introduced that aid in reducing blood volume and providing relief from different signs and symptoms of the disease.

Myelofibrosis Treatment Market Trends:

Factors like thrombocythemia, polycythemia vera, and exposure to industrial chemicals and high levels of radiation can increase the risk of myelofibrosis. As a result, the rising occurrence of these risk factors among a significant part of the population represents one of the key factors impelling the market growth. Moreover, as primary myelofibrosis is the most diagnosed disease among people of 50 years and above, the growing geriatric population and improving diagnostic modalities are positively influencing the demand for myelofibrosis treatment methods worldwide. Apart from this, increasing sales of new drugs that can assist in relieving chronic signs and symptoms of patients are driving the market. For instance, Janus kinase (JAK) inhibitors can lessen the symptoms of an enlarged spleen, night sweats, itching, and bone pain, while immunomodulators help in the normal functioning of the immune system. Furthermore, the increasing investments in research and development (R&D) activities are anticipated to advance the knowledge of myelofibrosis disease and its treatment options and impel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global myelofibrosis treatment market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug type, treatment type and end user.

Breakup by Drug Type:

  • Hydroxyurea
  • Immunomodulators
  • JAK Inhibitor
  • Others
     

Breakup by Treatment Type:

  • Blood Transfusion
  • Chemotherapy
  • Androgen Therapy
  • Stem Cell/Bone Marrow Transplantation
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Bone Marrow Transplant Centres
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AllCells LLC, American Type Culture Collection Inc, Amgen Inc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gilead Sciences Inc., Incyte Corporation, Merck & Co. Inc. and Novartis AG.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
 Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Million
Segment Coverage Drug Type, Treatment Type, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AllCells LLC, American Type Culture Collection Inc, Amgen Inc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gilead Sciences Inc., Incyte Corporation, Merck & Co. Inc. and Novartis AG
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global myelofibrosis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global myelofibrosis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global myelofibrosis treatment market and who are the key players?
  • What is the degree of competition in the industry?

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Myelofibrosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Clients Testimonial

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More